FIELD: pharmaceutics.
SUBSTANCE: invention relates to the pharmaceutical industry, namely to otorhinolaryngology, to the collection of mucolytic for the treatment of rhinosinusitis polyposa. The mucolytic preparation for the treatment of rhinosinusitis polyposa contains medicinal sage leaves, plantain leaves, coltsfoot leaves, goatweed grass, anise fruits and licorice roots taken in equal proportions.
EFFECT: mentioned collection has a pronounced mucolytic and anti-inflammatory effect in the nasal cavity in the treatment of rhinosinusitis polyposa.
1 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR SELECTING TARGETED THERAPY IN CHRONIC T2-INFLAMMATORY DISEASES OF NASAL CAVITY AND PARANASAL SINUSES | 2023 |
|
RU2824263C1 |
| METHOD OF POLYPOUS RHINOSINUSITIS TREATMENT | 2017 |
|
RU2646806C1 |
| METHOD FOR PHENOTYPE DETERMINATION OF CHRONIC INFLAMMATORY DISEASES OF NOSE AND PARANASAL SINUSES IN CASE OF INDICATIONS FOR TARGETED THERAPY | 2023 |
|
RU2826780C1 |
| USE OF PREPARATION CONTAINING AMMONIUM GLYCYRRHIZINATE AS ACTIVE INGREDIENT IN ANTI-INFLAMMATORY THERAPY OF POLYPOUS RHINOSINUSITIS | 2023 |
|
RU2817652C1 |
| METHOD FOR TREATING CHRONIC POLYPOUS RHINOSINUSITIS | 2000 |
|
RU2163097C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT AND PREVENTION OF UPPER RESPIRATORY TRACT DISEASES AND MEDICINAL PRODUCT BASED THEREON | 2019 |
|
RU2748548C1 |
| METHOD OF TREATING AND PREVENTING NASAL OBSTRUCTION IN PATIENTS SUFFERING POLYPOUS RHINOSINUSITIS | 2012 |
|
RU2499597C2 |
| METHOD OF TREATING CHRONIC RECURRING INFLAMMATORY DISEASES OF NASAL CAVITY AND PARANASAL SINISES BY METHOD OF ENDONASAL AUTOLYMPHOCYTO THERAPY | 2009 |
|
RU2403071C1 |
| METHOD FOR EVALUATING EFFICACY OF DRUG-INDUCED THERAPY OF POLYPOUS RHINOSINUSITIS | 2010 |
|
RU2428695C1 |
| METHOD OF TREATING ACUTE RHINOSINUSITIS IN CHILDREN | 2009 |
|
RU2407558C1 |
